Nassur, James A.
Samuel, Linsen T.
Acuña, Alexander J.
Ellsworth, Bridget
Kamath, Atul F. http://orcid.org/0000-0002-9214-2756
Article History
Received: 23 December 2022
Accepted: 26 June 2023
First Online: 6 July 2023
Change Date: 13 September 2023
Change Type: Correction
Change Details: A Correction to this paper has been published:
Change Details: https://doi.org/10.1007/s00402-023-05071-x
Declarations
:
: James A. Nassur, Linsen T. Samuel, Alexander J. Acuña, and Bridget Ellsworth have no relevant financial or non-financial interests to disclose. Atul Kamath is on the board or is a committee member of the American Academy of Orthopaedic Surgeons, the American Association of Hip and Knee Surgeons, and the Anterior Hip Foundation and receives no compensation from any of these organizations. Atul Kamath is a paid consultant to BodyCad, Ortho Development, United Ortho, and Zimmer. Atul Kamath owns IP royalties at Innomed and owns stock/stock options at Johnson & Johnson, Procter & Gamble, and Zimmer. Atul Kamath has received speaker honorarium from Zimmer.